Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Patent drug costs come under scrutiny as China looks to improve HIV treatment

This article was originally published in Scrip

Executive Summary

Spurred by the number of HIV carriers and AIDS patients in the country topping an estimated 780,000 by the end of 2011, China is to invest Yuan70 billion ($11 billion) by 2015 in the control of the disease, according to a new five-year plan released by the central government.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register